Business Description
The Oncology Institute Inc
NAICS : 621498
SIC : 8093
ISIN : US68236X1000
Description
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.69 | |||||
| Equity-to-Asset | 0.27 | |||||
| Debt-to-Equity | 2.1 | |||||
| Debt-to-EBITDA | -1.7 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.3 | |||||
| Beneish M-Score | -3.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.8 | |||||
| 3-Year EBITDA Growth Rate | -76.1 | |||||
| 3-Year EPS without NRI Growth Rate | -47.3 | |||||
| 3-Year FCF Growth Rate | -269.3 | |||||
| 3-Year Book Growth Rate | 20.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.57 | |||||
| 9-Day RSI | 34.66 | |||||
| 14-Day RSI | 35.52 | |||||
| 6-1 Month Momentum % | -26.24 | |||||
| 12-1 Month Momentum % | 207.15 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.12 | |||||
| Quick Ratio | 3.73 | |||||
| Cash Ratio | 2.38 | |||||
| Days Inventory | 15.87 | |||||
| Days Sales Outstanding | 50.2 | |||||
| Days Payable | 17.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.8 | |||||
| Shareholder Yield % | -66.46 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.37 | |||||
| Operating Margin % | -18.55 | |||||
| Net Margin % | -25.62 | |||||
| FCF Margin % | -12.61 | |||||
| ROE % | -95.44 | |||||
| ROA % | -36 | |||||
| ROIC % | -40.61 | |||||
| ROC (Joel Greenblatt) % | -104.77 | |||||
| ROCE % | -38.42 | |||||
| Years of Profitability over Past 10-Year | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.24 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 2.49 | |||||
| EV-to-EBIT | -1.52 | |||||
| EV-to-EBITDA | -1.65 | |||||
| EV-to-Revenue | 0.36 | |||||
| EV-to-FCF | -2.85 | |||||
| Earnings Yield (Greenblatt) % | -65.79 | |||||
| FCF Yield % | -51.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TOI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
The Oncology Institute Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 324.239 | ||
| EPS (TTM) ($) | -0.92 | ||
| Beta | 0 | ||
| Volatility % | 104.16 | ||
| 14-Day RSI | 35.52 | ||
| 14-Day ATR ($) | 0.141591 | ||
| 20-Day SMA ($) | 1.224 | ||
| 12-1 Month Momentum % | 207.15 | ||
| 52-Week Range ($) | 0.33 - 2.655 | ||
| Shares Outstanding (Mil) | 74.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
The Oncology Institute Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Oncology Institute Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
The Oncology Institute Inc Frequently Asked Questions
What is The Oncology Institute Inc(TOI)'s stock price today?
The current price of TOI is $1.07. The 52 week high of TOI is $2.66 and 52 week low is $0.33.
When is next earnings date of The Oncology Institute Inc(TOI)?
The next earnings date of The Oncology Institute Inc(TOI) is 2024-05-14.
Does The Oncology Institute Inc(TOI) pay dividends? If so, how much?
The Oncology Institute Inc(TOI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers